-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
How EpiPen’s maker raised prices, and hackles, so much
Bresch, the daughter of Sen. “I will observe, however, that pharmaceutical companies that often try to portray themselves as the inventors of life-saving medication often do real damage to their reputation by being greedy and jacking up prices”.
Advertisement
According to filings reported by NBC News, Mylan Pharmaceuticals CEO Heather Bresch’s yearly compensation rose from $2,453,456 in 2007 to $18,931,068 past year.
Two other senators, Democrats Mark Warner of Virginia and Richard Blumenthal of CT, also wrote the company about the high prices.
Klobuchar, voicing concerns for parents whose children have allergies, wants action. As for the more than 40% of children who are insured through Medicaid or the Children’s Health Insurance program, the increased price of EpiPens will result in higher costs to tax payers.
“My office has been contacted by dozens of concerned CT residents, families, school nurses, and first responders who urgently require your life-saving product but fear that its skyrocketing price has put it out of reach”.
Sen. Klobuchar wrote a letter to the Federal Trade Commission, calling for an investigation into whether Mylan Pharmaceuticals has engaged in activities, such as using incentives or exclusionary contracts with insurers, distributors, or pharmacies, to deny an alternative product access to the market.
Sen. Charles Grassley, R-Iowa, wrote Mylan, the company that manufactures the devices, and asked for more information on why the prices have increased. “From other Iowans I have heard concerns about the cost of EpiPens and the need to replace them once a year when they expire”.
In this Friday, July 8, 2016 photo, a pharmacist holds a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions, in Sacramento, Calif. Price hikes for the emergency medicine have made its maker, Mylan, the latest target for patients and politicians infuriated by soaring drug prices. She has released a proposal that she says will lower drug costs for consumers.
“It follows that numerous children who are prescribed EpiPens are covered by Medicaid and therefore the taxpayers are picking up the tab for this medication”, Grassley wrote.
Advertisement
Republican presidential candidate Donald Trump has said little about lowering drug prices.